This company listing is no longer active
S1K Stock Overview
A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Predictive Oncology Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.00 |
| 52 Week High | US$11.66 |
| 52 Week Low | US$4.00 |
| Beta | 1.49 |
| 1 Month Change | 0% |
| 3 Month Change | -17.36% |
| 1 Year Change | -51.87% |
| 3 Year Change | -85.82% |
| 5 Year Change | n/a |
| Change since IPO | -97.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| S1K | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.7% | -1.9% |
| 1Y | -51.9% | -13.8% | 9.1% |
Return vs Industry: S1K underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: S1K underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| S1K volatility | |
|---|---|
| S1K Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: S1K's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine S1K's volatility change over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 33 | Raymond Vennare | www.predictive-oncology.com |
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
Predictive Oncology Inc. Fundamentals Summary
| S1K fundamental statistics | |
|---|---|
| Market cap | €22.57m |
| Earnings (TTM) | -€23.03m |
| Revenue (TTM) | €1.28m |
17.7x
P/S Ratio-1.0x
P/E RatioIs S1K overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S1K income statement (TTM) | |
|---|---|
| Revenue | US$1.43m |
| Cost of Revenue | US$515.80k |
| Gross Profit | US$914.98k |
| Other Expenses | US$26.70m |
| Earnings | -US$25.79m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.44 |
| Gross Margin | 63.95% |
| Net Profit Margin | -1,802.42% |
| Debt/Equity Ratio | 0% |
How did S1K perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/07/19 00:33 |
| End of Day Share Price | 2023/04/21 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Predictive Oncology Inc. is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Swayampakula Ramakanth | H.C. Wainwright & Co. |
| Vernon Bernardino | H.C. Wainwright & Co. |